New Oral Treatments

Dr. Jeffrey Crowley, M.D.

Some of the latest treatments for psoriasis and psoriatic arthritis are oral medications with a novel approach to targeting psoriatic disease. But how do these treatments work, and who might they be right for? This webcast will discuss the latest and emerging oral treatments for psoriatic disease, including Otezla (apremilast) and Xeljanz (tofacitinib citrate). During this presentation, we’ll cover effectiveness, safety, and how to optimize your experience while taking one of these medications.

Curious as to whether one of these novel oral medications should be the next step in your psoriatic disease management plan? Bring your questions to this informative webcast led by Dr. Jeffrey Crowley, M.D. of Bakersfield Dermatology in Bakersfield, California.

Contact Bev Bromfield, Outreach Manager, at [email protected] or 800-723-9166, ext. 362.

The views and opinions expressed in the webcasts are those of the speakers. The speakers' views and opinions are not endorsed by the National Psoriasis Foundation or its sponsors.



This activity is supported by an education donation provided by Celgene. National Psoriasis Foundation is solely responsible for all content and development.

Browse additional webcasts by selecting the category tabs below